Oragenics, Inc.

US$0.35As of Sun 8 Nov 2026, 12:00 UTC
AMEX:OGENHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (63.07%)
Div yield —
ROE (1307.06%)
Biotechnology
Beta (5Y) 1.27
PE TTM —
TSR TTM (71.50%)
Mkt cap US$1.576M
ROIC (288.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.42
20.24%
(25.61%)
Sell 2|3|4|0|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
0.44%
7.48%
5.69%
18.39%
Revenue$M
0.174
0.181
0.175
0.173
2.49%
3.12%
1.46%
2.66%
Peers (US$1.575M)
Cap (US$)
PE
1.697M
—
1.436M
—
1.580M
—
Capital
TTM
5Y
10Y
Leveragex
0.978
0.455
0.417
EBIT/Intx
1.518
0.218
0.208
Own earn%
26.08
(57.11)
(56.42)
Sh yield%
12.05
37.99
38.50
Owners
Insiders/Inst%
12.39
39.36
Short interest%
1.89
SBC / revenue%
5.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
4